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Implementing an mHealth system for
substance use disorders in primary care:
a mixed methods study of clinicians’ initial
expectations and first year experiences
Marie-Louise Mares1* , David H. Gustafson2, Joseph E. Glass3, Andrew Quanbeck2, Helene McDowell1,
Fiona McTavish2, Amy K. Atwood3, Lisa A. Marsch4, Chantelle Thomas5, Dhavan Shah6, Randall Brown7,
Andrew Isham2, Mary Jane Nealon8 and Victoria Ward9
Abstract
Background: Millions of Americans need but don’t receive treatment for substance use, and evidence suggests
that addiction-focused interventions on smart phones could support their recovery. There is little research on
implementation of addiction-related interventions in primary care, particularly in Federally Qualified Health Centers
(FQHCs) that provide primary care to underserved populations. We used mixed methods to examine three FQHCs’
implementation of Seva, a smart-phone app that offers patients online support/discussion, health-tracking, and tools
for coping with cravings, and offers clinicians information about patients’ health tracking and relapses. We examined (a)
clinicians’ initial perspectives about implementing Seva, and (b) the first year of implementation at Site 1.
Methods: Prior to staggered implementation at three FQHCs (Midwest city in WI vs. rural town in MT vs.
metropolitan NY), interviews, meetings, and focus groups were conducted with 53 clinicians to identify core themes of
initial expectations about implementation. One year into implementation at Site 1, clinicians there were re-interviewed.
Their reports were supplemented by quantitative data on clinician and patient use of Seva.
Results: Clinicians anticipated that Seva could help patients and make behavioral health appointments more efficient,
but they were skeptical that physicians would engage with Seva (given high caseloads), and they were uncertain
whether patients would use Seva. They were concerned about legal obligations for monitoring patients’ interactions
online, including possible “cries for help” or inappropriate interactions. One year later at Site 1, behavioral health
care providers, rather than physicians, had incorporated Seva into patient care, primarily by discussing it during
appointments. Given workflow/load concerns, only a few key clinicians monitored health tracking/relapses and
prompted outreach when needed; two researchers monitored the discussion board and alerted the clinic as
needed. Clinician turnover/leave complicated this approach. Contrary to clinicians’ initial concerns, patients showed
sustained, mutually supportive use of Seva, with few instances of misuse.
Conclusions: Results suggest the value of (a) focusing implementation on behavioral health care providers rather than
physicians, (b) assigning a few individuals (not necessarily clinicians) to monitor health tracking, relapses, and the
discussion board, (c) anticipating turnover/leave and having designated replacements. Patients showed sustained,
positive use of Seva.
Trial registration: ClinicalTrials.gov (NCT01963234).
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Background
In 2013, an estimated 20 million Americans needed
treatment for an alcohol or drug problem but only 11%
of them received it [1]. This gap reflects both a serious
shortage of funding, specialist treatment providers and
treatment facilities [2, 3] and a variety of other barriers,
including stigma, logistics, and denial of a substance use
problem [4]. For many patients, primary care may be
one of few options for help.
Federal policy encourages primary care clinics to pro-
vide behavioral health care, including management of
substance use disorders [5, 6]. Federally Qualified Health
Centers (FQHCs) are a key part of that initiative. FQHCs
are primary care facilities (typically community health
centers), required to provide care to underserved popu-
lations, offer a sliding fee scale, treat all patients regard-
less of ability to pay, and provide comprehensive
services. Increasingly, those services include medical and
behavioral/mental health care for substance use disor-
ders [7].
Surveys of physicians indicate concerns about lack of
time to deal with the complex issues surrounding
addiction [8, 9] and lack of training and comfort dis-
cussing substance use with patients [10, 11]. Although
behavioral health clinicians (e.g., psychologists and clin-
ical social workers) may have more comfort and experi-
ence dealing with these issues, guidelines for behavioral
health consultations in primary care suggest that most
patients should be seen four times or less per year [12],
which (according to traditional treatment models) is
generally insufficient for those struggling with sub-
stance abuse [6].
In this context, a key question is whether mobile
technology could be used in primary health care to help
patients with substance use disorders. For patients,
smart phones can offer continuous access to support
for recovery and tools for positive behavior change,
supplementing and filling in the gaps between medical
and behavioral health appointments. For health-care
providers, patients’ relapse/health tracking reported on
the phone could inform treatment.
The Seva Project
Seva (from the Sanskrit for “selfless caring”) is an mHealth
system designed to support care for patients with sub-
stance use disorders. We received funding from the
National Institute for Drug Abuse to provide Seva to three
Federally Qualified Health Centers and examine effective
implementation strategies (see protocol paper, [13]).
For the patient, Seva is an application that lives on a
smart phone, with tools to support substance use treatment
(see Fig. 1). The tools for patients come from two previ-
ously tested health applications: A-CHESS (Addiction-
Comprehensive Health Enhancement Support System [14])
and TES (Therapeutic Education System [15]). A-CHESS
resources on the phone include health tracking, a discus-
sion board populated by patients in the study, and tools for
coping with cravings and high-risk situations (e.g., relax-
ation exercises and links to local Twelve Step meetings). In
a randomized trial in residential addiction treatment cen-
ters, patients assigned to A-CHESS had significantly fewer
risky drinking days and significantly higher rates of abstin-
ence post-discharge than those in the control group [16].
TES, the second piece incorporated into patients’
Seva app on the phone, is a web- and mobile-based
curriculum for addiction treatment, comprised of 65
interactive modules designed to teach problem solving,
self-regulation, coping, and lifestyle restructuring skills.
When used in a model that partially replaced clinician-
delivered therapy, TES produced significantly better
addiction treatment outcomes, relative to a model
where behavioral therapy was delivered entirely by cli-
nicians [15, 17]. The 21 TES modules included in
Fig. 1 Main menu of Seva on patients’ smartphones
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SEVA covered communication skills (10), triggers (3),
HIV/Hepatitis (4), decision making and problem solv-
ing (4).
For clinicians, Seva provides a web portal called the
Clinician Report (see Fig. 2) containing longitudinal in-
formation generated by patients’ use of Seva (e.g., weekly
health-tracking surveys, including reports of relapses).
Clinicians visiting the portal see a graph of participating
patients’ scores over time. In a randomized trial of a
cancer-related CHESS program, patients whose CHESS
system included Clinician Reports (relative to those
without the Report) showed significantly faster improve-
ments in self-reported health status [18].
As shown in Table 1, we selected three very different
FQHCs: the first in Madison, WI (midsize, midwest
city), the second in Missoula, MT (town, rural setting),
and the third in the Bronx, NY (metropolitan area).
Implementation at each site was staggered at 6 months
intervals. At each site, Seva is provided to 100 patients
(aged 18 or older, diagnosed with substance use dis-
order, attended a medical and a behavioral health ap-
pointment at the site in the past year).
The first part of this paper focuses on clinicians’ initial
expectations about Seva. We report qualitative data on
themes that emerged at all three sites, to identify core
issues that are likely to arise whenever such systems are
implemented into FQHCs. The second focuses on the
first year of implementation experiences at Site 1 only
(given staggered implementation). We use mixed methods
to describe a) implementation decisions to address clini-
cians’ concerns, (b) clinicians’ use and perceptions of Seva
by the end of that first year, and (c) the extent to which
their patients’ use of Seva was consistent with clinicians’
initial expectations.
Methods
Participants
Clinicians
As Table 1 shows, a total of 53 clinicians from three
sites gave written consent to participate (i.e., to be
interviewed or participate in focus groups and to have
access to the Clinician Report). Two of the clinicians at
Site 1 were also members of the research team. Data
about clinicians’ initial expectations came from all three
sites; data about experiences during the first year came
from clinicians at Site 1 only (n = 17) given staggered
implementation.
Patients at Site 1
A total of 120 patients were referred for participation at
Site 1. Of those, 95 successfully completed the intake ses-
sion (consent form and baseline survey) and subsequent
Fig. 2 Mockup of clinician report showing hypothetical patient profiles
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training session. Of those 95 participants, 18 were dropped
(e.g., lost to contact, lost multiple phones), leaving 77 at
the end of the first year (M age = 41.6; 53.6 % female). Of
these 77 participants, 38 % had a high school education or
less, 46.4 % had some college or 2-year college, and 14 %
had a BA or higher. With regard to race and ethnicity,
70 % identified as White, 31 % as African American,
4.3 % as American Indian or Alaskan Native, and 1 %
as Hispanic. At baseline, 61.4 % of the 77 said they were
very or quite comfortable using the Internet, 20.8 %
said they were somewhat comfortable, and 17.7 % said
they were not at all or a little bit comfortable.
Sources of Data
About clinicians’ initial expectations
Data about initial expectations were gathered in the 6
months prior to implementation and in the first 2
months of implementation. As shown in the upper sec-
tion of Table 2, data came from interviews and focus
group with clinicians at all three sites, and notes from
research team meetings that included the two clinician
team members.
About first year of implementation at Site 1
As the lower portion of Table 2 shows, data about
ongoing implementation decisions came from weekly re-
search team meetings throughout the first year that
included two clinician team members from Site 1. Data
about Site 1 clinicians’ use and perceptions of Seva 1 year
into implementation came from in-depth interviews and
meetings with clinicians, and quantitative data about
clinician use of the Clinician report. Data about Site 1
patients’ engagement with Seva came from quantitative
data captured every time they logged into Seva, and
qualitative examination of their interactions on the Seva
discussion board. As patients were informed during the
consent process, all of their activity on Seva is captured
and stored in a database. For privacy reasons, no data
are gathered about non-Seva uses of the phone, such as
text messaging or phone calls.
Data collection
In all but two instances, meetings, interviews, and focus
groups were not audio-recorded. Rather, the lead author
took detailed notes as a form of quasi-transcription.
Table 1 Characteristics of research sites
Site 1 Site 2 Site 3
Madison, WI Missoula, MT Bronx, NY
N N N
Patient Characteristics
Number of Patients Served Prior Year 25,062 9,087 6,677
% White 60.5 91.0 3.4
% African American 25.4 1.0 32.2
% Asian 5.4 1.0 0.8
% American Indian/Alaska Native 8.2 5.0 0.4
% Hispanic 26.7 3.5 58.2
% Other 2.0
Provider Characteristics
N Medical Providers at site
(MD, Resident, PA)
30 42 13
n Enrolled in Seva Project 3 (10 %) 25 0
N Nurses at site
(RN, LPN, MA)
40 32 14
n Enrolled in Seva Project 4 (10 %) 1 1
N Behavioral Health at site
(LMSW, LMHC, LCSW, PsyD., PhD., MD)
10 8 11
n Enrolled in Seva Project 10 (100 %) 4 5
Clinic Characteristics
Medical and behavioral health care co-located Yes Yes Yes
Warm handoffs to behavioral health staff Yes Yes Yes
Substance use disorder focus Medical & BHC team focused
on substance use
Addiction & mental health
support group
Addiction & mental health
support group
Setting Midwest US, mid-size city Western State, small city hub
for rural-frontier counties
East Coast, US Metropolitan
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After each session, she went through the notes to make
additions and corrections and to organize the material.
She then summarized key findings or themes and dis-
seminated them to the research team to critique and
verify the synthesis. To verify the accuracy and com-
pleteness of this approach, two sessions were audio-
recorded. Comparison of coding from the detailed notes
versus transcripts from audio recordings of these two
sessions indicated no differences.
Data analysis
Notes and transcripts were analyzed using thematic
analysis. The lead author identified key sections to be
coded, developed a coding scheme, and coded all key
sections. A second coder (a student) independently
coded a random selection of 4 research team meetings
and 4 in-depth interviews. Krippendorff ’s alpha was
above .80 for all themes.
Results
Clinicians’ Initial Expectations: Data from All Three Sites
The aim was to identify core themes regarding clinicians’
expectations about Seva that were evident at all three
research sites-issues that were raised consistently, des-
pite differences in the clinics' geographic setting,
organizational structure, etc. Some were predictable con-
cerns about workflow and workload that often arise at
implementations in healthcare settings [e.g., [19]]. Other
concerns and anticipated benefits are unique to the issue
of using an mHealth intervention in primary care to
support management of substance use disorders. Table 3
summarizes core concerns in order of number of clini-
cians who independently raised each theme. Table 4
summarizes anticipated benefits. The numbers under-
estimate support for each theme, given that they do not
reflect clinicians who nodded agreement during meet-
ings or focus groups.
Initial Concerns
Concerns about clinician time and workflow
As Table 3 shows, the most frequently mentioned concern
was about workflow (when/how to check the Clinician
Report, issues of interface with the Electronic Medical
Record and logging in) and having adequate time assigned
to Seva monitoring and patient outreach. Clinic adminis-
trators and behavioral health clinicians were particularly
Table 2 Data collection matrix
Method/data source Study population Participants and number of sessions
Studying Clinicians’ Initial Expectations at All Three Sites
Meetings/Focus Group Discussions Clinic Staff - Behavioral health care providers with high volume of patients
with substance use disorders
o Madison: 2 sessions
o Missoula: 2 sessions
Clinic Staff - Medical &/or behavioral health care providers with varied
volume of patients with substance use disorders
o Madison: 2 sessions
o Missoula: 1 session
o Bronx: 2 sessions
In-Depth Individual Interviews Clinic Staff - Administration: 1–2 interviews per site
- Behavioral health care providers: 1 interview per site
- Medical Assistant and Nurses:1–3 per site
Research Team Meeting Notes Clinician champions of Seva
on research team
- 15 meetings of 5–9 researchers, including two clinicians from
Site 1, and occasional call-ins from clinicians from Sites 2 and 3.
Studying First Year Implementation Experiences at Site 1
Meetings toward the end of the
first year
Clinic staff at first site - Medical & behavioral health care providers with varied use
of Seva: 1 session
- Behavioral health care providers with varied use of Seva:
1 session
In-Depth individual interviews toward
the end of the first year
Clinic staff at first site - Physician with no use of Seva: 1 interview
- Nurse with limited use of Seva: 1 interview
- Behavioral health care providers with varied use of Seva:
4 interviews
Computer Data on Clinician Use
of Report
Clinic staff at first site - Log-in data from 17 clinicians participating in study
Research Team Meeting Notes Clinician champions of Seva
on research team
- 20 meetings of 5–9 researchers, including two clinicians
from 1st site
Computer Data on Patient Use of Seva Patients at first site - Log-in data from 97 patients
Note. All consented clinicians or administrative stakeholders participated in at least one of the above forms of data collection. The number of participants at each
session varied
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concerned that physicians would not engage with Seva,
given high case-loads. At Sites 1 and 2 (midWest city,
rural city respectively), physicians thought the Report
looked interesting, but were dubious they would use it for
the small subset of their patients with substance use disor-
ders, particularly if it required a separate log in. At Site 3,
the clinic did not introduce Seva to physicians due to
these concerns.
Concerns about whether and how patients would use Seva
Clinicians noted the complex mental and physical co-
morbidities often facing this patient population, and
were concerned whether patients would learn how to
use Seva, and whether some would sell the smartphone,
lose it, or break it. Additionally, they wondered whether
patients would use the discussion board inappropriately
(e.g., engage in hostile interactions or try to sell or buy
drugs).
Concerns about legal obligations and liability
Clinicians wanted to be certain that patients would under-
stand that their healthcare providers could see anything
they did on Seva. This was particularly an issue given that
patients’ disclosures on Seva about relapses could affect
their treatment (e.g., clinicians’ decisions about medi-
cations). Additionally, clinicians were concerned that
patients might use Seva to indicate that they were feel-
ing suicidal (or wanted to hurt someone) and that the
clinic (or they themselves) would be liable if no-one
responded. No site wanted to be responsible for moni-
toring patients’ posts or health-tracking responses.
Expectations of Benefits
Seva as a resource for patients
As shown in Table 4, the most commonly anticipated
benefit of Seva was as a resource for high need patients
facing key transitions (e.g., coming out of jail), or who
had few other sources of sobriety support (e.g., “had
burned their bridges”), or who needed alternatives to
group meetings such as AA/NA meetings or group ther-
apy. Some individuals had mental health issues that
made it difficult for them to benefit from group interac-
tions; some lived in isolated communities which made it
embarrassing and stressful to attend local sobriety
Table 3 Core themes in clinicians’ initial concerns about implementing Seva
Qualitative Themes (N Independent Mentions) Exemplar Quotations
Concerns about workflow and time
Fitting it in to the workflow (10) We’re so busy here. What’s the right workflow? How do we interface the systems? Don’t make me
log in to another system, don’t send me an email attachment, don’t make me open a document.
How will this fit into the huddle?
Difficult to engage physicians (8) I’ve talked to [some doctors] but they’re pretty overwhelmed right now… Medical providers have
so many pieces they use right now, I just don’t think that they would log on.
Having time for Seva (7) I’m in a storm and can’t really see out of the storm. I worry about having another thing added if
I don’t get extra time carved out for it.
Encourage needy patients (4) I worry that this is going to increase burden on staff. Some of these patients are in bad shape
and out of control. I worry they will use the phones to hound the staff even more.
Other initiatives compete for time & energy (3) A lot of things start to happen and then don’t stick. Some pan out and some don’t… We were
going to be involved in a brain mapping system and that didn’t pan out because of funding
and logistics. And we’re very close to contracting with a casino upstate to be gambling treatment
providers. And, 2015, we have a big depression care initiative. And we have to meet the demands
of all these licensing bodies.
Concerns about legal obligations & liability
Possible unanswered suicidality on the
discussion board (5)
I could be held liable. I could lose my license. I am uncomfortable with the idea of giving out the
phone and not getting this information directly…People who are not me making clinical decisions
about my patients. If one of our patients were to do something self-injurious, I would be thoroughly
investigated, and this is never far from my mind.
Patients understand what clinicians can see (4) Particularly when there are possible disclosures about substance use that have not previously
been shared with the medical team and place them at risk based on their current medication
regimen (someone is disclosing heavy benzo use while on suboxone for one example)…
I want to be upfront for their protection and for ours-it’s my license if I’m documenting stuff.
Concerns about patients’ use of Seva
Not use Seva or misuse the phone (6) My biggest fear is patients not using or misusing the system. That they’d just be signing up to get
a free phone and then they’d be pawning it or that they’d throw it in the river.
Toxic interactions on discussion board (6) Particularly when individuals are reaching out during low moments, their pre-existing negative
emotional valence may be inadvertently infused into their interpretation of the messages
and statements they are reading, particularly if the messages are ambiguous, have multiple
meanings, or are written poorly.
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support groups. The constant accessibility of Seva on
the phone was seen as a way for patients to experience
continuity of sobriety support between appointments, or
at moments when clinicians were not immediately able
to respond.
Clinician Report as a resource
Behavioral health clinicians anticipated that their ap-
pointments and outreach could become more efficient,
given access to patients’ health tracking scores. Add-
itionally, clinic administrators and behavioral health care
providers noted that if physicians did use Seva, it might
increase their comfort discussing addiction with patients
and increase their referrals to behavioral health.
The mobile phone as a resource
The fact that Seva is offered on a mobile phone (as op-
posed to other platforms) was seen as beneficial in
various ways. Clinicians noted that some patients with
substance use disorders have volatile living situations,
including frequent changes in address and loss of
phone service. Providing them with a stable phone
number could facilitate appointment reminders and
case management between appointments, and might
reduce patient attrition. It could also help patients find
critical resources (e.g., homeless shelters) or reach out
to crisis hotlines. Additionally, offering the smart-
phone to patients who are often highly stigmatized
could serve as a sign of trust and respect.
First Year of Implementation Experiences: Data from Site 1
The clinic context
Several features of Site 1 are particularly relevant to the
implementation of an addiction-targeted mHealth sys-
tem. First, behavioral health care is integrated with med-
ical care-they are situated in the same building, and if
physicians learn that a patient has substance use issues
they can have the patient meet a behavioral health care
provider immediately (“a warm handoff”). Second, the
clinic has a multi-disciplinary “Health Promotions” team
with expertise in health care needs of patients at risk for
adverse consequences of tobacco, alcohol, prescribed
Table 4 Core themes in clinicians’ initial expectations of benefits of implementing Seva
Qualitative Themes (N independent mentions) Exemplar Quotations
Seva as a resource for patients
With few other sobriety resources (6) Missoula has nothing long term for patients with substance use issues. There’s only one
4-bed share house. Turning Point, the only outpatient program has a long waiting list.
There’s nothing else in town. People basically have AA or [the clinic’s] sobriety group.
And for people who live further out of town in a small community, or on the reservations?
This is something we can offer them.
As a tool for learning and insight (5) Their lack of language to talk about emotions is really profound. They can’t explain what
happened, don’t know how to tune into different feelings, so they turn to substances.
A powerful part of the process is teaching them how to recognize emotions and providing
them with options. So just filling out the BAM [Brief Alcohol Monitoring Scale… on Seva]
is a powerful tool.
Who need an alternative to group meetings (5) Often they want to be alone-they’re often living in shelters that are very chaotic, and they
just want peace and quiet…. So Seva would allow them to interact without really being part
of a group. They can get their toe in the water.
To experience constant availability of sobriety
support (4)
Often a patient is trying to reach out to me but I’m busy and won’t get the message till five
hours later. I really like that in the meantime, the phone can help them with their breathing
exercises or he can listen to a podcast to help him figure out why he shouldn’t relapse,
and that’s great.
At key transitions (4) This has so many positive possibilities. Like being able to help people coming out of rehab,
or from mental health inpatient, or coming out of jail and they need that support to help
them now they’re back in the community.
Clinician Report as a resource for clinicians
More efficient appointments (10) If they can be filling out the PHQ [Patient Health Questionnaire] ahead of time on the phone, and
if I can see that, that saves me a ton of time. That can make our meetings a lot more efficient.
Prompt primary care conversations about
addiction (6)
Addictions are so often kept secretive in a medical visit, being able to talk about it is really
important. If we could give it to the medical provider, it would be really good. It could start
the conversation.
Mobile phone as a resource
For patients (5) Having a phone helps them move into housing, they can call the hotline phone number at
the homeless shelter, people can be calling in for help with issues.
For clinic (5) So many of these patients don’t have voicemail, don’t have a phone system. Now suddenly
we can access them. It suddenly lets us have contact… so we could remind them, “oh
you’ve got this appointment” or we can reach out, “hey, just checking in.”
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controlled substances, and other drugs. Given this, re-
sponsibility for addressing issues related to risky and
problem substance use and psychoactive medications
often falls on behavioral health and on Health Promo-
tions. Third, two clinicians from Site 1 are members of
the Seva research team and serve as champions of the
project at the clinic. They identified the initial set of
patients for recruitment, facilitated intake sessions, were
the first to use the Clinician Report for patient care, dis-
seminated information from the Clinician Report to other
clinicians, and provided near-weekly feedback about im-
plementation issues as they arose.
Implementation Decisions During the First Year at Site 1
Various strategies evolved over the first year, in response
to clinicians’ initial concerns.
In response to concerns about monitoring
Clinicians wanted assurances that someone would moni-
tor the discussion board daily, but given their workload
did not want to do so themselves. It was agreed that two
non-clinic members of the research team would monitor
the board daily, remove any inappropriate content, con-
tact the patient and their behavioral health care provider
as needed, and write responses to patients so that no-
one was left unanswered.
In response to concerns about liability
Given clinician concerns about transparency, patients
were explicitly told that their healthcare team could see
all their responses on Seva. Participants specifically
consented to exchanges of information about their sub-
stance use between the researchers and healthcare pro-
viders. Behavioral health clinicians often discussed Seva
during appointments, further highlighting the potential
visibility of their responses.
Given clinician concerns about liability if patients
expressed suicidal or dangerous ideation, the intake
and training sessions emphasized that Seva was not a
way to reach clinic staff in an emergency. Seva itself
included on-screen text: “If you are in crisis or thinking
about harming yourself, please call (number for suicide
hotline)”. This message showed on-screen whenever the
patient hit the panic button, or responded negatively to
the daily query about making it through the day. The
two research team members who monitored the discus-
sion board contacted relevant behavioral health clini-
cians if patients indicated they were in crisis.
In response to concerns about logging in to Clinician Report
Clinicians were initially concerned about the inconveni-
ence of logging in to the Clinician Report, and particu-
larly skeptical that physicians would take the time to do
so. Over the first year, the clinic developed a model in
which a few clinicians agreed to log in once or twice a
week and share actionable information with other behav-
ioral health clinicians so that outreach could take place
if needed.
Clinician Use of the Clinician Report
At the end of the first year of implementation (with
11 months of Clinician Report availability), 5 of the 17 cli-
nicians had never accessed the Clinician Report, 9 showed
very limited use (M = 3.56 days total logged in during
11 months), and 3 showed extensive use (M = 71.68 days
logged in during 11 months). The most extensive use was
by a behavioral health care provider assigned to check
the Report and share actionable items (e.g., relapses)
with other behavioral health care providers. The two
clinicians who were members of the research team also
logged in frequently and disseminated information to
other clinicians. Additionally, toward the end of the
first year, two clinicians (one nurse, and the behavioral
health research team member) set up email alerts so
they would be notified directly if a patient on Seva re-
ported a relapse (i.e., reported using drugs or alcohol).
Although this evolving system avoided the burden as-
sociated with everyone logging in to the Report, it was
susceptible to personnel change. The behavioral health
consultant assigned to check the Report weekly left the
clinic, as did the nurse who signed up for email alerts.
One of the two champions of Seva took maternity leave
for part of the year. This placed more emphasis on the
research team members who monitored the discussion
board to act as information hubs.
Clinician Perceptions of Seva
Toward the end of the first year, clinicians were asked
about their perceptions of Seva. Their responses were
coded with regard to the core themes from the pre-
implementation phase.
As a resource for patient care
Clinicians on the addiction-focused Health Promotions
Team, and behavioral health care providers perceived
that many of the anticipated benefits of Seva (reported
1 year earlier) had been realized. Although most of
them did not log in to the Clinician Report, they re-
ported discussing Seva with patients during appoint-
ments, including encouraging use of specific features
(e.g., the learning modules and relaxation podcasts). All
said that their patients valued the constant accessibility
of support. As anticipated, Seva provided an alternative
for patients who (for various reasons) did not want to
attend group therapy and/or were not interested in
various other forms of treatment. A behavioral health
care provider noted,
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“Several people who are using it the most are people
who’ve failed out of other treatments or burned out
on people telling them how to change. They really
appreciate the autonomy to choose as much or as
little as is really helpful.”
Clinicians also noted that patients were learning from
the educational material on Seva.
“One thing that’s really interesting is to look at
language they’re picking up from the modules.
I had one man who didn’t have much vocabulary
for insight before, and I recently heard him talking
about self-sabotage and triggers, and he got that
from the modules.”
The main exception to benefits anticipated and achieved
for patients was the possibility that patient-generated data
on Seva would help primary care physicians discuss sub-
stance use with their patients. As one physician reported,
“ To be honest, some of my patients are using Seva
and I’ve never even seen them. I know they’re on it
because I get a notification, as their PCP… but they’re
typically pretty healthy and haven’t had other PCP
needs… or I’m not usually talking about it with them
because I’m talking about other stuff.”
Thus, Seva was part of treatment for substance use dis-
orders at the clinic, but it was implemented by the
addiction-focused Health Promotions team and behavioral
health care providers, rather than primary care physicians.
Perceived impact on workload and flow
When asked about the impact of Seva on their work
load and flow, the behavioral health care providers noted
the substantial burden added by the tasks of recruiting
patients and coordinating intake and training sessions
(“but I was okay with that, because I was committed to
the project”). Among the few who regularly logged in to
the Clinician Report, there was clearly some effort in-
volved, but also a sense of routine.
It’s not really making more work. I try to log into
Seva when I start my shift, unless I get really slammed
at the start of the shift. I try to keep up with the
Discussion Board. I look to see who has used
[alcohol or drugs] recently and whether they’ve had
other support from us. If they have used and we
haven’t seen them in a while, I will give them a call.
Among those who did not log in to the Clinician Re-
port (i.e., received Seva information from colleagues
designated to log in), the response was very positive.
“Oh no, Seva makes less work, it doesn’t make more.
Once we figured it out, it makes it easier to help
patients, we knew we had extra thing for them.
It’s really something helpful, an extra resource.”
At the same time, those behavioral health consultants
who did not access the Clinician Report saw little likeli-
hood that they would do so in the future. As anticipated,
they felt it was too hard to fit in to their established rou-
tines and busy schedule.
“I just haven’t figured out a way to incorporate it
into the workflow. I rely on [specified clinicians]
reaching out to me, like they’ll tell me that there’s a
post that’s concerning around safety and risk. I just
haven’t used it, just because of the workflow issues.
I think when you’re trying to change workflow
habits, that’s really hard.”
Despite their initial concerns, they did not perceive
that patients became more demanding and needy as a
result of having access to Seva and a study-provided
smartphone.
Minimal concerns about liability
Although some clinicians had initially expressed con-
cerns about liability, at follow-up they did not have such
concerns. They felt confident that the discussion board
was being monitored and that patients understood what
could be seen.
Evidence about Patients’ Use of Seva
Clinicians were initially somewhat dubious about pa-
tients’ use of Seva and the phone. One year later, data
about patients’ patterns of use speaks to these issues.
Lost and broken phones
An initial concern was that patients would lose, sell, or
break their phones. Of 97 patients enrolled, 14 patients
lost or broke their phone. Of these, half were replaced
because the patients had shown high levels of engage-
ment with Seva.
Levels of engagement
Clinicians wondered whether their patients would actu-
ally engage with Seva, or “just sign up to get a free
phone.” As can be seen in Fig. 3, 80 % or more of partic-
ipants at Site 1 logged on at least once per week for the
first 20 weeks that they were on the study (not including
time spent on training). During weeks 21–41, the per-
cent logging in continued to be high (70–92 %) and the
median days per week logging in remained above 5.5.
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Interactions on the discussion board
Clinicians initially expressed concern that patients might
use the discussion board inappropriately. Hundreds of
messages were posted over the course of the year, and
there were few problematic incidents. One involved an
increasingly hostile series of posts between two partici-
pants over whether it was necessary to report a relapse.
A third participant posted a warning that they were
risking access to Seva and sent a private message to the
research team, asking them to step in. In a second in-
stance, a participant complained about a frustrating
day, and asked (in an ambiguously joking way) if any-
one knew where she could buy heroin. Other partici-
pants promptly posted rebukes (“not cool”) and
contacted the researchers. In both cases, the problem-
atic content was removed, the individuals were warned
privately by the support team, and continued on study
without further incident. Thus, the group engaged in
constructive and effective self-policing, combined with
daily monitoring and responses from the two appointed
members of the research team.
Discussion
At all three sites, clinicians’ initial concerns focused on
workload and workflow, but also on issues of whether
patients with substance use disorders would engage with
Seva and use it appropriately, and issues of clinic liability
if patients’ use of Seva were not adequately monitored.
During the first year of implementation at Site 1, a num-
ber of strategies emerged to mitigate these concerns. Seva
was used by behavioral health care providers and the
addiction-focused Health Promotions team, not by physi-
cians. A few key clinicians undertook the task of checking
the Clinician Report and sharing information with others
as needed. This strategy reduced burden, but was prob-
lematic when those key individuals took leave or took jobs
elsewhere. Concerns about liability for unanswered “cries
for help” on Seva and possible inappropriate use of Seva
were addressed by having two members of the research
team (rather than clinicians) monitor the discussion board
and contact the clinic as needed.
Initially, clinicians at all three sites perceived that pa-
tients with substance use disorders were a high-need
Fig. 3 Patients’ use of Seva at site 1, reported by patients’ week on study
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population that would benefit from the continuous
access to social support and recovery tools on Seva.
After a year of implementation, behavioral health care
providers at Site 1 felt that their patients were indeed
benefiting. Although there were some losses of the
phone, patients showed high levels of sustained engage-
ment with Seva and appropriate, supportive use of the
discussion board.
Limitations
It remains to be seen whether these experiences and
strategies change over time and whether they are shared
by the other two clinics. These are primarily qualitative
data, reflecting clinicians’ self-reported experiences and
perceptions.
Conclusions
MHealth interventions for substance use disorders may
face some issues during implementation in primary care
settings. These include clinic concerns about who will
monitor patients’ interactions online, clinicians’ lack of
time to monitor patients’ online health tracking, and the
reluctance of physicians to engage with such a system.
Nonetheless, the current study also indicates that behav-
ioral health clinicians perceived substantial benefits of
such an intervention for their patients and that the pa-
tients showed sustained use of it over the year, with sup-
portive, appropriate interactions.
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